Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Self-controlled Cohort Study of the Amplification and Selection of Antimicrobial Resistance in the Human Intestine

NCT02058888 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02058888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Self-controlled Cohort Study of the Amplification and Selection of Antimicrobial Resistance in the Human Intestine
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
May 31, 2017
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukaemia